Breast Cancer | Novartis Philippines

Media Release
Jul 22, 2024
Novartis, Asian Hospital launch partnership to enhance health literacy and broaden access to innovative medicines for breast cancer and dyslipidemia
Media Release
May 16, 2024
Novartis, Philippine Press Institute, ICanServe recognize journalists and newspapers for impactful breast cancer stories
Media Release
Jul 12, 2023
Inspiring Conversations on Breast Cancer: Roundtable Series to Improve Survivorship in the Philippines
Media Release
Jun 06, 2023
Novartis, Philippine Press Institute, ICanServe Foundation partner on media workshop to enhance breast cancer knowledge
Media Release
Apr 27, 2023
Novartis medicine, ribociclib, prolongs progression-free survival for pre- and perimenopausal patients with aggressive HR+/HER2− metastatic breast cancer compared to chemotherapy
Media Release
Mar 27, 2023
Novartis' Ribociclib Phase III NATALEE trial shows significant benefit for patients with early breast cancer in interim analysis
Media Release
Jan 11, 2023
ICanServe, Taguig City, Dashlabs, Novartis launch data-digital project to support breast cancer control program